CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-04-01 | Kammer Robert J Director | Sale | −10,000 | $4.77 | $48K | 849,827 |
| 2019-03-01 | Kammer Robert J Director | Sale | −10,000 | $6.91 | $69K | 859,827 |
| 2019-02-19 | SAHAREK JOHN P. Chief Commercial Officer | Grant or award · Option - Right to Buy | +50,000 | 50,000 | ||
| 2019-02-19 | SAHAREK JOHN P. Chief Commercial Officer | Grant or award · Restricted Stock Unit | +50,000 | 50,000 | ||
| 2019-02-19 | BOLL ANDREW R. Chief Financial Officer | Grant or award · Option - Right to Buy | +50,000 | 50,000 | ||
| 2019-02-19 | BOLL ANDREW R. Chief Financial Officer | Grant or award · Restricted Stock Unit | +50,000 | 50,000 | ||
| 2019-02-19 | BAUM MARK L Chief Executive Officer | Grant or award · Option - Right to Buy | +150,000 | 150,000 | ||
| 2019-02-01 | Kammer Robert J Director | Sale | −10,000 | $5.86 | $59K | 869,827 |
| 2019-01-02 | Kammer Robert J Director | Sale | −10,000 | $5.33 | $53K | 879,827 |
| 2018-12-03 | Kammer Robert J Director | Sale | −10,000 | $4.64 | $46K | 889,827 |
| 2018-11-01 | Kammer Robert J Director | Sale | −10,000 | $4.21 | $42K | 899,827 |
| 2018-10-15 | Kammer Robert J Director | Sale | −10,000 | $3.00 | $30K | 909,827 |
| 2018-09-04 | Kammer Robert J Director | Sale | −10,000 | $3.00 | $30K | 919,827 |
| 2018-08-10 | Kammer Robert J Director | Sale | −130,000 | $3.00 | $390K | 929,827 |
| 2018-06-29 | LINDSTROM RICHARD L MD Director | Grant or award · RSU | +34,091 | 34,091 | ||
| 2018-06-29 | Kammer Robert J Director | Grant or award · RSU | +34,091 | 34,091 | ||
| 2018-06-29 | Principi Anthony Director | Grant or award · RSU | +34,091 | 34,091 | ||
| 2018-06-29 | AUSTIN STEPHEN G Director | Grant or award · RSU | +34,091 | 34,091 | ||
| 2018-02-01 | SAHAREK JOHN P. Chief Commercial Officer | Option exercise | +30,000 | $1.83 | $55K | 30,000 |
| 2018-02-01 | SAHAREK JOHN P. Chief Commercial Officer | Option exercise · Restricted Stock Unit | −30,000 | 30,000 |
Page 14 of 17 · 336 trades